Barron's - USA (2020-08-03)

(Antfer) #1

August 3, 2020 BARRON’S M7


INSIDE SCOOP


AT&TDirector Luczo


LoadsUpontheStock


that he filed with the Securities and


Exchange Commission. Luczo’s trust


now owns 300,000 AT&T shares.


AT&T declined to comment on the


stock purchase, and also declined to


make Luczo, a formerSeagate


Technology(STX) CEO and


chairman, available for comment.


Luczo has been the most active


buyer of AT&T stock among insiders


this year. He paid $1.1 million on April


22 for 36,000 AT&T shares, an


average per share price of $29.38. In


February, Luczo paid $3.8 million for


100,000 AT&T shares, an average


price of $37.60 each.


Credit Suisse analyst Douglas


Mitchelson kept a Neutral rating on


AT&T stock with a $33 target price


after the second-quarter report.


“[W]e struggle to see growth in


2021 earnings before interest, taxes,


depreciation, and amortization,”


he wrote.B


AT&T director


Stephen Luczo


continues to buy


slumping shares


of the telecom and


media giant.He


paid $3 million in


late July for more


AT&T stock.


prise participated in the IPO, pur-


chasing 666,666 Nkarta shares at


the offering price. The rest of New


Enterprise’s position resulted in the


conversion of pre-IPO preferred


securities into common stock in


connection with the IPO’s close.


New Enterprise now holds 9.5% of


Nkarta’s tradable stock.


Increases in


Holdings


ViaSat(VSAT)


Baupost Grouplifted its holding


of the satellite and wireless com-


munications firm to 16,288,959


shares. Baupost revealed that it


purchased 2,556,891 ViaSat shares


on July 22 through a private offer-


ing priced at $39.11 apiece. After


the fresh investment, Baupost now


owns a 24.1% interest in ViaSat’s


outstanding stock.


Pearson(PSO)


Cevian Capitalpurchased


10,795,992 ordinary shares of the


educational and professional-


development company. Cevian


bought those Pearson shares from


July 15 through July 29 at per share


prices ranging from $6.62 to $7.24.


Cevian’s fresh investment followed


a previous disclosure that it had


added slightly more than 12.2 mil-


lion Pearson shares from late June


through July 14. All told, Cevian


now owns 63,646,039 ordinary


Pearson shares, equal to 8.5% of


the tradable stock.


Decreases in


Holdings


Callaway Golf(ELY)


Jana Partnerstrimmed its posi-


tion in the golf-accessories com-


pany to 4,636,858 shares. Without


citing a reason, Jana sold 1,331,054


Callaway shares from June 22


through July 21 at prices ranging


from $17.20 to $18.90 each. Jana’s


moves cut its Callaway stake by


nearly a quarter, reducing its dis-


closed ownership to a current 4.9%


from 6.3% in mid-June.


Battlefor


CoreLogicIs


HeatingUp


POWER PLAY


A


T&Tstock has lost about


a quarter of its value so far


this year, but one of the


company’s newest


directors, Stephen Luczo,


recently bought a large


block of shares of the


telecom and media giant.


In July, AT&T’s new CEO John


Stankey presided over the company’s


second-quarter report, which was


mixed. Wireless and business wireline


results were strong, but WarnerMedia


and DirecTV were challenged. None-


theless, earlier this year, AT&T (ticker:


T) said it was committed to paying its


dividend, now yielding about 7%.


Luczo, who joined AT&T’s board


last year, paid $3 million on July 23 for


100,000 shares, a per share average


price of $29.69. He made the purchase


through a trust, according to a form


By ED LIN


T


here has been a paucity of


activist fights to track in


2020, but signs suggest that


one of this year’s battles is


shaping up to be a bruiser.


Back in June, activist investor


Senator Investment Group part-


nered with strategic holding com-


panyCannae Holdings(ticker:


CNNE) to acquire real-estate-data


firmCoreLogic(CLGX) at $65 a


share. Potential deal activity was


welcomed by investors, with shares


swiftly climbing above the offering


price, and recently trading just


above $67. But CoreLogic rebuffed


the offer, saying that it “signifi-


cantly undervalues” the company.


This week, however, the duo


turned up the heat on CoreLogic


after what it called a series of “delay


tactics,” including the introduction


of a poison pill to prevent a take-


over. Senator and Cannae are now


seeking another investor to join


their side so they can reach the 10%


stake needed to call a special meet-


ing in early October and replace


nine members of CoreLogic’s 12-


person board with a slate that will


facilitate a sale process.


The duo claims a 15% “economic


interest” in CoreLogic, including


derivatives, but fell just short of the


10% ownership of common shares


needed to call a meeting.


Signs point to a contentious


battle ahead. Senator and Cannae’s


proposed board nominees include


Katherine Rabin, former CEO of


proxy advisory firm Glass Lewis,


and Gail Landis, a current board


member atMorningstar(MORN).


CoreLogic contends that the bid


undervalues the company, pointing


to its “strong” guidance through


2022—though analysts questioned


that rosy outlook.


Buckle up, because this fight is


still in the first round.B


By CARLETON ENGLISH


Activist Holdings


Virtusa(VRTU)


New Mountain Vantage Advisers


disclosed an interest of 2,979,665


shares of the enterprise information-


technology-services firm, equal to


9.9% of Virtusa’s outstanding stock.


Including cash derivatives, New


Mountain’s economic exposure to


Virtusa now stands at 10.8%. On


July 27, New Mountain delivered a


letter to Virtusa requesting a copy


of its books and records per Dela-


ware corporate law. New Mountain


wants to review several Virtusa


items, including its reported first-


quarter margins, executive compensa-


tion, and the reason behind the disso-


lution of the board’s Finance Com-


mittee, among others. New Mountain


has not revealed any specific proposals


or proxies related to the request.


Original Filings


Nkarta(NKTX)


New Enterprise Associatesrevealed


an initial position in the oncology bio-


tech firm of 2,902,115 shares. Nkarta


recently debuted publicly through a


July 9 initial public offering that was


priced at $18 per share. New Enter-


These disclosures are


from 13Ds filed with


the Securities and


Exchange Commission.


13Ds are filed within


10 days of an entity’s


attaining more than


5% in any class of a


company’s securities.


Subsequent changes


in holdings or inten-


tions must be re-


ported in amended


filings. This material is


from July 23 through


July 29, 2020. Source:


InsiderScore.com

Free download pdf